Tremelimumab is one of several drugs that are in development as a treatment for malignant mesothelioma. As discussed in a recent article from FDA News Alert, for patients, a mesothelioma diagnosis is one of the scariest things they can hear. It is a rare illness and there is no cure. Essentially, when a patient learns that he or she has mesothelioma, they are generally told that there is little doctors can do and that the prognosis is normally death within a few months to a few years.
It should be said that this does not mean there are no treatment options for malignant mesothelioma. It is that there aren’t many effective ones. At best, doctors have been able to slightly slow the growth of these deadly and aggressive and tumors, but nobody goes into remission like they do with other types of cancer. Continue reading
Mesothelioma Lawyers Blog










